Ginsenoside Rg1 alleviates corticosterone-induced dysfunction of gap junctions in astrocytes
Ginsenoside Rg1 alleviates corticosterone-induced dysfunction of gap junctions in astrocytes
复制标题
人参皂苷 Rg1 减轻皮质酮诱导的星形胶质细胞间隙连接功能障碍
DOI:
10.1016/j.jep.2017.06.031
复制
发表时间:
2017
影响因子:
5.4
通讯作者:
Chen Nai-Hong
中科院分区:
文献类型:
--
作者:
Xia Cong-Yuan;Chu Shi-Feng;Zhang Shuai;Gao Yan;Ren Qian;Lou Yu-Xia;Luo Piao;Tian Man-Tong;Wang Zhi-Qi;Du Guo-Hua;Tomioka Yoshihisa;Yamakuni Tohru;Zhang Yi;Wang Zhen-Zhen;Chen Nai-Hong
Ethnopharmacological relevanceGinsenoside Rg1 (Rg1), one of the major bioactive ingredients ofPanax ginsengC. A. Mey, has neuroprotective effects in animal models of depression, but the mechanism underlying these effects is still largely unknownAim of the studyGap junction intercellular communication (GJIC) dysfunction is a potentially novel pathogenic mechanism for depression. Thus, we investigated that whether antidepressant-like effects of Rg1 were related to GJIC.Materials and methodsPrimary rat prefrontal cortical and hippocampal astrocytes cultures were treated with 50 μM CORT for 24 h to induce gap junction damage. Rg1 (0.1, 1, or 10 μM) or fluoxetine (1 μM) was added 1 h prior to CORT treatment. A scrape loading and dye transfer assay was performed to identify the functional capacity of gap junctions. Western blot was used to detect the expression and phosphorylation of connexin43 (Cx43), the major component of gap junctions.ResultsTreatment of primary astrocytes with CORT for 24 h inhibited GJIC, decreased total Cx43 expression, and increased the phosphorylation of Cx43 at serine368 in a dose-dependent manner. Pre-treatment with 1 μM and 10 μM Rg1 significantly improved GJIC in CORT-treated astrocytes from the prefrontal cortex and hippocampus, respectively, and this was accompanied by upregulation of Cx43 expression and downregulation of Cx43 phosphorylation.ConclusionThese findings provide the first evidence indicating that Rg1 can alleviate CORT-induced gap junction dysfunction, which may have clinical significance in the treatment of depression.